Literature DB >> 8660335

Vascular endothelial growth factor is induced by long-term high glucose concentration and up-regulated by acute glucose deprivation in cultured bovine retinal pigmented epithelial cells.

H Sone1, Y Kawakami, Y Okuda, S Kondo, M Hanatani, H Suzuki, K Yamashita.   

Abstract

Vascular endothelial growth factor (VEGF) is closely correlated to diabetic retinopathy. Its basal production in three types of cultured retinal cells (endothelial cells, pericytes and retinal pigment epithelial cells; RPE) was examined. RPE production of VEGF was markedly higher than the rest of the cells. VEGF production in RPE was significantly elevated by 10-day, but not by 1- or 3-day exposure to 16.5 mM glucose compared to a 5.5 mM glucose group. Transient deterioration of diabetic retinopathy is frequently observed during rapid correction of glycemic control. To determine whether VEGF is up-regulated following a sharp drop in the glucose concentration or not, we examined the changes in VEGF production in RPE before and after a sudden drop in the glucose concentration. VEGF production was significantly increased by a glucose concentration decrease from 5.5 to 0.5 mM, but not by a decrease from 33 or 16.5 to 5.5 mM. These findings suggest that up-regulation of VEGF may contribute to the development of diabetic retinopathy and its worsening by hypoglycemia.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8660335     DOI: 10.1006/bbrc.1996.0568

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  27 in total

Review 1.  The role of inflammation in diabetic eye disease.

Authors:  Marina Mesquida; Faye Drawnel; Sascha Fauser
Journal:  Semin Immunopathol       Date:  2019-06-07       Impact factor: 9.623

2.  VEGF-A regulates the expression of VEGF-C in human retinal pigment epithelial cells.

Authors:  B Zhao; A Ma; J Cai; M Boulton
Journal:  Br J Ophthalmol       Date:  2006-05-10       Impact factor: 4.638

Review 3.  Microvascular modifications in diabetic retinopathy.

Authors:  Jennifer T Durham; Ira M Herman
Journal:  Curr Diab Rep       Date:  2011-08       Impact factor: 4.810

Review 4.  Dietary hyperglycemia, glycemic index and metabolic retinal diseases.

Authors:  Chung-Jung Chiu; Allen Taylor
Journal:  Prog Retin Eye Res       Date:  2010-09-22       Impact factor: 21.198

5.  A prospective study on hyperglycemia and retinopathy of prematurity.

Authors:  L Mohsen; M Abou-Alam; M El-Dib; M Labib; M Elsada; H Aly
Journal:  J Perinatol       Date:  2014-03-27       Impact factor: 2.521

6.  Vascular dysfunction induced by elevated glucose levels in rats is mediated by vascular endothelial growth factor.

Authors:  R G Tilton; T Kawamura; K C Chang; Y Ido; R J Bjercke; C C Stephan; T A Brock; J R Williamson
Journal:  J Clin Invest       Date:  1997-05-01       Impact factor: 14.808

7.  Expression of vascular endothelial growth factor in the human retina and in nonproliferative diabetic retinopathy.

Authors:  C Gerhardinger; L F Brown; S Roy; M Mizutani; C L Zucker; M Lorenzi
Journal:  Am J Pathol       Date:  1998-06       Impact factor: 4.307

8.  Proliferative diabetic retinopathy and relations among antioxidant activity, oxidative stress, and VEGF in the vitreous body.

Authors:  Hiroshi Izuta; Nozomu Matsunaga; Masamitsu Shimazawa; Tetsuya Sugiyama; Tsunehiko Ikeda; Hideaki Hara
Journal:  Mol Vis       Date:  2010-01-29       Impact factor: 2.367

9.  Resveratrol ameliorates high-glucose-induced hyperpermeability mediated by caveolae via VEGF/KDR pathway.

Authors:  Chong Tian; Rui Zhang; Xiaolei Ye; Changhui Zhang; Xin Jin; Yukio Yamori; Liping Hao; Xiufa Sun; Chenjiang Ying
Journal:  Genes Nutr       Date:  2012-09-16       Impact factor: 5.523

10.  Extracellular SOD and VEGF are increased in vitreous bodies from proliferative diabetic retinopathy patients.

Authors:  Hiroshi Izuta; Yuichi Chikaraishi; Tetsuo Adachi; Masamitsu Shimazawa; Tetsuya Sugiyama; Tsunehiko Ikeda; Hideaki Hara
Journal:  Mol Vis       Date:  2009-12-10       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.